Zujun Fang
- Topics
- Bladder and Urothelial Cancer Treatments (8 papers)Renal cell carcinoma treatment (7 papers)Cancer and Skin Lesions (6 papers)
- Cited by
- GeneticsUrologyCancer Research
- Partner nations
- ChinaUnited StatesAustria
In The Last Decade
Zujun Fang
36 papers receiving 511 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 258
- Surgery 139
- Oncology 135
- Genetics 98
- Pulmonary and Respiratory Medicine 93
Countries citing papers authored by Zujun Fang
This map shows the geographic impact of Zujun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zujun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zujun Fang more than expected).
Fields of papers citing papers by Zujun Fang
This network shows the impact of papers produced by Zujun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zujun Fang. The network helps show where Zujun Fang may publish in the future.
Co-authorship network of co-authors of Zujun Fang
This figure shows the co-authorship network connecting the top 25 collaborators of Zujun Fang. A scholar is included among the top collaborators of Zujun Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zujun Fang. Zujun Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 18 | |
| 6 | 4 | |
| 7 | Randomized clinical trial evaluating safety and efficacy of propiverine ER 30 mg and tolterodine ER 4 mg in the treatment of overactive bladder | 1 |
| 8 | 33 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 9 | |
| 12 | 10 | |
| 13 | 30 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 9 | |
| 17 | 3 | |
| 18 | 120 | |
| 19 | 9 | |
| 20 | 32 |
About Zujun Fang
Zujun Fang is a scholar working on Dermatology, Urology and Cancer Research, having authored 38 papers that have together received 523 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Cancer and Skin Lesions (6 papers). The work is most often cited by research in Genetics (98 citations), Urology (37 citations) and Cancer Research (83 citations). Zujun Fang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Qiang Ding, Haowen Jiang, Zhong Wu, Peng Gao, Guowei Xia, Hui Wen, Chenchen Feng, Qiang Ding, Guanxiong Ding and Zhihua Kang. Their work appears in journals such as PLoS ONE, The American Journal of Surgical Pathology and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.